Integrated Filing — IndAS


General information about company

Scrip Code 530117
NSE Symbol PRIVISCL
MSEI Symbol NOTLISTED
ISIN INE959A01019
Name of company Privi Speciality Chemicals Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 03-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 22-Apr-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Aroma Chemical Manufacturing
Start date and time of board meeting 03-May-2025   12:30:00
End date and time of board meeting 03-May-2025   15:00:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-02-12
Indicate Company website link for updated RPT policy of the Company https://www.privi.com/Downloads/Policies-PSCL/PSCL-Policy-on-Related-Party-Transactions-V-1-2.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
No default on loan



Financial Results Ind-AS

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 5807285000 20383426000
Other income 141708000 179047000
Total income 5948993000 20562473000
2 Expenses
(a) Cost of materials consumed 3034939000 11413273000
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 188330000 -357449000
(d) Employee benefit expense 194406000 751505000
(e) Finance costs 213731000 837931000
(f) Depreciation, depletion and amortisation expense 317772000 1266794000
(f) Other Expenses
1 Power and fuel expense 379844000 1518300000
2 Other expenses 737513000 2593428000
Total other expenses 1117357000 4111728000
Total expenses 5066535000 18023782000
3 Total profit before exceptional items and tax 882458000 2538691000
4 Exceptional items 0 0
5 Total profit before tax 882458000 2538691000
6 Tax expense
7 Current tax 235879000 656327000
8 Deferred tax -14650000 -10661000
9 Total tax expenses 221229000 645666000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 661229000 1893025000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 661229000 1893025000
17 Other comprehensive income net of taxes -4092000 -7761000
18 Total Comprehensive Income for the period 657137000 1885264000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 390627000 390627000
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 10621300000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 16.93 48.46
Diluted earnings (loss) per share from continuing operations 16.93 48.46
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 16.93 48.46
Diluted earnings (loss) per share from continuing and discontinued operations 16.93 48.46
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 9356323000
Capital work-in-progress 562857000
Investment property 0
Goodwill 0
Other intangible assets 433798000
Intangible assets under development 138682000
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 617054000
Trade receivables, non-current 0
Loans, non-current 0
Other non-current financial assets 180864000
Total non-current financial assets 797918000
Deferred tax assets (net) 151294000
Other non-current assets 354422000
Total non-current assets 11795294000
2 Current assets
Inventories 7226711000
Current financial asset
Current investments 0
Trade receivables, current 4007614000
Cash and cash equivalents 405845000
Bank balance other than cash and cash equivalents 679000
Loans, current 0
Other current financial assets 1298218000
Total current financial assets 5712356000
Current tax assets (net) 0
Other current assets 0
Total current assets 12939067000
3 Non-current assets classified as held for sale 0
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 24734361000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 390627000
Other equity 10621300000
Total equity attributable to owners of parent 11011927000
Non controlling interest
Total equity 11011927000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 2791338000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 27412000
Total non-current financial liabilities 2818750000
Provisions, non-current 225417000
Deferred tax liabilities (net) 222195000
Deferred government grants, Non-current 0
Other non-current liabilities 0
Total non-current liabilities 3266362000
Current liabilities
Current financial liabilities
Borrowings, current 5686293000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 124311000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 3926908000
Total Trade payable 4051219000
Other current financial liabilities 658878000
Total current financial liabilities 10396390000
Other current liabilities 31642000
Provisions, current 28040000
Current tax liabilities (Net) 0
Deferred government grants, Current 0
Total current liabilities 10456072000
3 Liabilities directly associated with assets in disposal group classified as held for sale 0
4 Regulatory deferral account credit balances and related deferred tax liability 0
Total liabilities 13722434000
Total equity and liabilites 24734361000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurements of the net defined benefit plans -5475000 -10408000
Total Amount of items that will not be reclassified to profit and loss -5475000 -10408000
2 Income tax relating to items that will not be reclassified to profit or loss -1383000 -2647000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0 0
5 Total Other comprehensive income -4092000 -7761000



Cash flow statement, indirect

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 2024-04-01
B Date of end of reporting period 2025-03-31
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 2538691000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 837931000
Adjustments for decrease (increase) in inventories -1198455000
Adjustments for decrease (increase) in trade receivables, current -400907000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets -733843000
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current -4525000
Adjustments for other financial assets, current -101000
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 1217577000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 25634000
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 1261302000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 4120000
Adjustments for provisions, current 0
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 0
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains 196392000
Adjustments for dividend income 0
Adjustments for interest income 1408000
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 0
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 1153000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) 1204870000
Net cash flows from (used in) operations 3743561000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 703104000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 3040457000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 34496000
Purchase of property, plant and equipment 1512705000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 1408000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 35672000
Net cash flows from (used in) investing activities -1441129000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 2167179000
Repayments of borrowings 2571676000
Payments of lease liabilities 46326000
Dividends paid 78125000
Interest paid 822011000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities -1350959000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 248369000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents -32000
Net increase (decrease) in cash and cash equivalents 248337000
Cash and cash equivalents cash flow statement at beginning of period 157508000
Cash and cash equivalents cash flow statement at end of period 405845000







Details of Impact of Audit Qualification

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 M/s. B S R & Co., LLP Yes 31-Jul-2028


Financial details

Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income
2 Total Expenditure
3 Net Profit/(Loss)
4 Earnings Per Share
5 Total Assets
6 Total Liabilities
7 Net Worth




Signatories detail

Name of CEO / Managing director
Name of CFO
Name of audit committee chairman
Name of statutory auditor
Name of other signatory, if any, with designation
Place
Date



Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Privi Speciality Chemicals Limited Moneymart Securities Private Limited Enterprises owned by key management personnel or their relatives Any other transaction Lease Expenses NA 10933000 1979000 119000
2 Privi Speciality Chemicals Limited Moneymart Securities Private Limited Enterprises owned by key management personnel or their relatives Any other transaction Lease Income NA 69000 0 0
3 Privi Speciality Chemicals Limited MM Infra and Leasing Private Limited Enterprises owned by key management personnel or their relatives Any other transaction Lease Income NA 4498000 0 4000
4 Privi Speciality Chemicals Limited MM Infra and Leasing Private Limited Enterprises owned by key management personnel or their relatives Any other transaction Lease Income NA 66000 0 0
5 Privi Speciality Chemicals Limited Vivira Investment & Trading Pvt. Ltd Enterprises owned by key management personnel or their relatives Any other transaction Lease Income NA 30000 0 0
6 Privi Speciality Chemicals Limited Privi Fine Sciences Pvt. Ltd. Enterprises owned by key management personnel or their relatives Any other transaction Lease Income NA 30000 0 0
7 Privi Speciality Chemicals Limited Privi Biotechnologies Pvt. Ltd Enterprises owned by key management personnel or their relatives Any other transaction Lease Income NA 30000 0 0
8 Privi Speciality Chemicals Limited Privi Life Sciences Private Limited Enterprises owned by key management personnel or their relatives Any other transaction Lease Income NA 2205000 10628000 13601000
9 Privi Speciality Chemicals Limited Prigiv Specialties Private Limited Subsidiary Any other transaction Lease Income NA 600000 0 354000
10 Privi Speciality Chemicals Limited Privi Life Sciences Private Limited Enterprises owned by key management personnel or their relatives Purchase of goods or services NA 0 41000 0
11 Privi Speciality Chemicals Limited Prasad Organics Private Limited Enterprises owned by key management personnel or their relatives Sale of goods or services NA 114556000 892000 86509000
12 Privi Speciality Chemicals Limited Prasad Organics Private Limited Enterprises owned by key management personnel or their relatives Purchase of goods or services NA 190771000 18272000 45903000
13 Privi Speciality Chemicals Limited Privi Fine Sciences Pvt. Ltd. Enterprises owned by key management personnel or their relatives Purchase of goods or services NA 251000 0 5272000
14 Privi Speciality Chemicals Limited Privi Fine Sciences Pvt. Ltd. Enterprises owned by key management personnel or their relatives Any other transaction Job Work Charges paid NA 16160000 3752000 4671000
15 Privi Speciality Chemicals Limited Privi Fine Sciences Pvt. Ltd. Enterprises owned by key management personnel or their relatives Sale of goods or services NA 6007000 2609000 506000
16 Privi Speciality Chemicals Limited Doppalapudi Bhaktavatsala Rao Key management Personnel Remuneration NA 1200000 200000 167000
17 Privi Speciality Chemicals Limited Mahesh P Babani Key management Personnel Remuneration NA 21000000 3500000 2172000
18 Privi Speciality Chemicals Limited Vinaykumar Doppalapudi Rao Relative of Key management Personnel Remuneration NA 0 0 0
19 Privi Speciality Chemicals Limited Prigiv Specialties Private Limited Subsidiary Investment NA 0 178500000 178500000
20 Privi Speciality Chemicals Limited Prigiv Specialties Private Limited Subsidiary Any other transaction Reimbursement of Expenses NA 4526000 2559000 9168000
21 Privi Speciality Chemicals Limited Privi Speciality Chemicals USA Corporation Subsidiary Purchase of goods or services NA 637425000 53902000 227026000
22 Privi Speciality Chemicals Limited Privi Speciality Chemicals USA Corporation Subsidiary Sale of goods or services NA 1920313000 717925000 956758000
23 Privi Speciality Chemicals Limited Privi Speciality Chemicals USA Corporation Subsidiary Advance NA 88375000 12603000 88375000
24 Privi Speciality Chemicals Limited Privi Biotechnologies Private Limited Subsidiary Any other transaction Technical Fees Paid NA 24000000 5478000 16437000
25 Privi Speciality Chemicals Limited Privi Biotechnologies Private Limited Subsidiary Any other transaction Lease Expenses NA 4500000 0 0
26 Privi Speciality Chemicals Limited Mahesh P Babani Key management Personnel Any other transaction Unsecured loan taken NA 0 650000000 0
27 Privi Speciality Chemicals Limited Privi Biotechnologies Private Limited Subsidiary Any other transaction Unsecured loan taken NA 0 70000000 25000000
28 Privi Speciality Chemicals Limited Mahesh P Babani Key management Personnel Interest paid NA 18659000 12758000 0
29 Privi Speciality Chemicals Limited Privi Biotechnologies Private Limited Subsidiary Interest paid NA 1560000 0 0
30 Privi Speciality Chemicals Limited Dwarko Topandas Khilnani Non-Executive Independent Directors Any other transaction Sitting Fees Paid NA 400000 0 0
31 Privi Speciality Chemicals Limited Anurag Surana Non-Executive Independent Directors Any other transaction Sitting Fees Paid NA 400000 0 0
32 Privi Speciality Chemicals Limited Anuradha Thakur Non-Executive Independent Directors Any other transaction Sitting Fees Paid NA 400000 0 0
33 Privi Speciality Chemicals Limited MR. HEMANG GANDHI Non-Executive Independent Directors Any other transaction Sitting Fees Paid NA 300000 0 0
34 Privi Speciality Chemicals USA Corporation Privi Fine Sciences Pvt. Ltd. Enterprises owned by key management personnel or their relatives Purchase of goods or services NA 0 6672000 0
35 Prigiv Specialties Private Limited MM Infra and Leasing Private Limited Enterprises owned by key management personnel or their relatives Any other transaction Lease Expenses NA 25178000 6566000 9724000
36 Prigiv Specialties Private Limited MM Infra and Leasing Private Limited Enterprises owned by key management personnel or their relatives Any other transaction Expenses Reimbursement NA 880000 0 0
37 Prigiv Specialties Private Limited Mr. Narendra Kumar Ambwani Non-Executive Independent Directors Any other transaction Sitting Fees Paid NA 20000 0 0
38 Prigiv Specialties Private Limited Dwarko Topandas Khilnani Non-Executive Independent Directors Any other transaction Sitting Fees Paid NA 20000 0 0
39 Prigiv Specialties Private Limited Givaudan-SA JV Partner Sale of goods or services NA 19376000 0 19376000
40 Prigiv Specialties Private Limited Givaudan -Finance S A Associate of JV Partner Interest paid NA 28902000 0 28902000
41 Prigiv Specialties Private Limited Givaudan India Pvt Ltd Associate of JV Partner Interest paid NA 61955000 0 111304000
42 Prigiv Specialties Private Limited Givaudan -Finance S A Associate of JV Partner Loan NA 820000000 0 820000000
43 Prigiv Specialties Private Limited Givaudan India Pvt Ltd Associate of JV Partner Inter-corporate deposit NA 0 800000000 800000000
44 Prigiv Specialties Private Limited Privi Fine sciences P. Ltd Enterprises owned by key management personnel or their relatives Sale of goods or services NA 1955000 0 0
Total value of transaction during the reporting period 4027550000





Format for Disclosing Outstanding Default on Loans and Debt Securities

Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
3. Total financial indebtedness of the listed entity including short-term and long-term debt